Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
Prostaglandins and thromboxane are lipid signaling molecules deriving from arachidonic acid by the action of the cyclooxygenase isoenzymes COX-1 and COX-2. The role of cyclooxygenases (particularly COX-2) and prostaglandins (particularly PGE2) in cancer-related inflammation has been extensively inve...
Main Authors: | Alessandra Pannunzio, Mauro Coluccia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/11/4/101 |
Similar Items
-
Analysis of the Activity and Expression of Cyclooxygenases COX1 and COX2 in THP-1 Monocytes and Macrophages Cultured with Biodentine<sup>TM</sup> Silicate Cement
by: Katarzyna Barczak, et al.
Published: (2020-03-01) -
The Influence of Glycosylation of Natural and Synthetic Prenylated Flavonoids on Binding to Human Serum Albumin and Inhibition of Cyclooxygenases COX-1 and COX-2
by: Tomasz Tronina, et al.
Published: (2017-07-01) -
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
by: Chitra Rawat, et al.
Published: (2019-10-01) -
Flavanones from Sorghum bicolor selectively inhibit COX-2: in-silico and in-vivo validation
by: O. Adeboye Akinloye, et al.
Published: (2019-12-01) -
COX-2 in Cancer: Gordian knot or Achilles heel?
by: Ioannis eStasinopoulos, et al.
Published: (2013-03-01)